Iván Schwartzmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Iván Schwartzmann has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
Juan Palou Redorta
Department of Urology, Fundació Puigvert, Spain
17 shared publications- Alberto Breda
Unit of Uro-oncology and Kidney Transplant, Department of Urology, Puigvert Foundation, Universitat Autònoma de Barcelona (UAB), 08025 Barcelona, Spain
4 shared publications J. Planas
Departamento de Urología y Trasplante Renal, Hospital Universitario Vall d'Hebrón, Universidad Autónoma de Barcelona, Barcelona, España
3 shared publications- Ana Celma
Department of Urology, Hospital Univeritari Vall d´Hebron, Barcelona, Spain, Spain
2 shared publications Humberto Villavicencio
Department of Urology, Fundació Puigvert, Universidad Autónoma de Barcelona, Barcelona, Spain
2 shared publicationsJ. Morote
Departamento de Urología y Trasplante Renal, Hospital Universitario Vall d'Hebrón, Universidad Autónoma de Barcelona, Barcelona, España; Universidad Autónoma de Barcelona, Barcelona, España
2 shared publications
Latest Publications
- Open Access
- 16 October 2026
- Published by Springer Nature in Research Square
Postoperative Urinary Tract Infection Following Water Vapor Thermal Therapy
Purpose Urinary tract infection (UTI) is frequently reported after water vapor thermal therapy (WVTT), but its true rate remains uncertain because expected postoperative irritative symptoms may mimic infection and standardized definitions have been lacking. We evaluated postoperative infectious complications after WVTT using a recently established international consensus definition of UTI. Methods This international multicentre cohort study included consecutive patients undergoing WVTT between January 2020 and December 2025. Prospectively collected clinical data were retrospectively analysed. Postoperative episodes considered clinically suspicious for infection were classified according to the consensus definition proposed by Bilsen et al. as confirmed, probable, possible, or no UTI. The primary endpoint was confirmed/probable UTI within 30 days. Results Among 278 patients, 58 (21%) experienced a postoperative episode considered clinically suspicious for infection. Application of the consensus definition identified 26 confirmed and three probable UTIs, corresponding to a 30-day confirmed/probable UTI rate of 10%. Postoperative antibiotics were prescribed in 61 patients (22%), of whom 33 (54%) did not fulfil criteria for confirmed/probable UTI. No statistically significant association was observed between preoperative bacteriuria and confirmed/probable postoperative UTI. Conclusion Standardized assessment identified confirmed/probable UTI in 10% of patients after WVTT, substantially fewer than clinically suspected infections. These findings highlight the value of standardized definitions for reporting postoperative UTI and guiding antibiotic use.
- 16 October 2026
- Published by Springer Nature in Research Square
Open AccessPostoperative Urinary Tract Infection Following Water Vapor Thermal Therapy
Purpose Urinary tract infection (UTI) is frequently reported after water vapor thermal therapy (WVTT), but its true rate remains uncertain because expected postoperative irritative symptoms may mimic infection and standardized definitions have been lacking. We evaluated postoperative infectious complications after WVTT using a recently established international consensus definition of UTI. Methods This international multicentre cohort study included consecutive patients undergoing WVTT between January 2020 and December 2025. Prospectively collected clinical data were retrospectively analysed. Postoperative episodes considered clinically suspicious for infection were classified according to the consensus definition proposed by Bilsen et al. as confirmed, probable, possible, or no UTI. The primary endpoint was confirmed/probable UTI within 30 days. Results Among 278 patients, 58 (21%) experienced a postoperative episode considered clinically suspicious for infection. Application of the consensus definition identified 26 confirmed and three probable UTIs, corresponding to a 30-day confirmed/probable UTI rate of 10%. Postoperative antibiotics were prescribed in 61 patients (22%), of whom 33 (54%) did not fulfil criteria for confirmed/probable UTI. No statistically significant association was observed between preoperative bacteriuria and confirmed/probable postoperative UTI. Conclusion Standardized assessment identified confirmed/probable UTI in 10% of patients after WVTT, substantially fewer than clinically suspected infections. These findings highlight the value of standardized definitions for reporting postoperative UTI and guiding antibiotic use.
- 15 July 2026
- Published by Elsevier in European Urology Focus
Re: Manuel Ritter, Johannes Stein, Neil Barber, et al. WATER III: A Prospective, Partially Randomized Trial of Aquablation Therapy Versus Transurethral Laser Enucleation of the Prostate for Treatment of Lower Urinary Tract Symptoms. Eur Urol Focus 2026;12:266-274.
- 15 July 2026
- Published by Elsevier in European Urology Focus
Re: Manuel Ritter, Johannes Stein, Neil Barber, et al. WATER III: A Prospective, Partially Randomized Trial of Aquablation Therapy Versus Transurethral Laser Enucleation of the Prostate for Treatment of Lower Urinary Tract Symptoms. Eur Urol Focus 2026;12:266-274.
- Open Access
- 13 May 2026
- Published by BioExcel in Drugs in Context
- Vol. 15, 1-17
Efficacy and safety of Serenoa repens in benign prostatic disorders: a systematic review of recent clinical evidence
This systematic review comprehensively evaluates literature from the past 5 years on the efficacy and safety of Serenoa repens in the treatment of benign prostatic disorders, either as monotherapy or in combination with other treatments.
- 13 May 2026
- Published by BioExcel in Drugs in Context
- Vol. 15, 1-17
Open AccessEfficacy and safety of Serenoa repens in benign prostatic disorders: a systematic review of recent clinical evidence
This systematic review comprehensively evaluates literature from the past 5 years on the efficacy and safety of Serenoa repens in the treatment of benign prostatic disorders, either as monotherapy or in combination with other treatments.
- 22 April 2025
- Published by Elsevier in European Urology Focus
- Vol. 11 (4) , 551-552
Practical Approaches to Evaluating Patients with Benign Prostatic Hyperlasia Using Home-based Tools and Apps
- 22 April 2025
- Published by Elsevier in European Urology Focus
- Vol. 11 (4) , 551-552
Practical Approaches to Evaluating Patients with Benign Prostatic Hyperlasia Using Home-based Tools and Apps
- 10 February 2025
- Published by Elsevier in Actas Urológicas Españolas (English Edition)
- Vol. 49 (4) , 501695
Mastering the curve: Advances and challenges in teaching endoscopic enucleation of the prostate
- 10 February 2025
- Published by Elsevier in Actas Urológicas Españolas (English Edition)
- Vol. 49 (4) , 501695
Mastering the curve: Advances and challenges in teaching endoscopic enucleation of the prostate
- 13 April 2023
- Published by H1 Connect
Faculty Opinions recommendation of Bacterial characteristics and clinical significance of ureteral double-J stents in children.
The authors evaluated the incidence of positive double-J stent culture and of febrile urinary tract infection (UTI) after surgical procedure in a paediatric population. All patients received prophylaxis with amoxicillin. Around 59% of double-J stents had a positive culture. Of these, only 28% of bacteria in the stent culture were sensitive to amoxicillin. Despite of this finding, only 6% of patients presented febrile UTI. The authors observed there was little correlation between catheter bacterial colonization and the incidence of UTI and that profilaxis with amoxicillin was probably of little use.
- 13 April 2023
- Published by H1 Connect
Faculty Opinions recommendation of Bacterial characteristics and clinical significance of ureteral double-J stents in children.
The authors evaluated the incidence of positive double-J stent culture and of febrile urinary tract infection (UTI) after surgical procedure in a paediatric population. All patients received prophylaxis with amoxicillin. Around 59% of double-J stents had a positive culture. Of these, only 28% of bacteria in the stent culture were sensitive to amoxicillin. Despite of this finding, only 6% of patients presented febrile UTI. The authors observed there was little correlation between catheter bacterial colonization and the incidence of UTI and that profilaxis with amoxicillin was probably of little use.
- 16 March 2023
- Published by H1 Connect
Faculty Opinions recommendation of Thulium Fibre Laser versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial.
This interesting study by Ulvik et al. compared the performance of two lasers for the treatment of upper urinary tract stones by retrograde intrarenal surgery (RIRS). One group used a 30W Holmium:yttrium-aluminum-garnet (Ho:YAG) laser and the other group a 60W Thulium fiber laser (TFL). Both groups started with similar lasing parameters, but it was allowed for the surgeon to change them during surgery. TFL was found to be superior regarding surgical time and stone-free rate. Some limitations of the study should be pointed out: 1) its single center design, 2) laser settings could be modified during surgery, and 3) probably the most important limitation was that laser power for Ho:YAG was half of the TFL. There is no comment in the article about how the sample size was calculated. An other study with a high power Ho:YAG laser didn’t observe the same differences between both groups {1}.
- 16 March 2023
- Published by H1 Connect
Faculty Opinions recommendation of Thulium Fibre Laser versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial.
This interesting study by Ulvik et al. compared the performance of two lasers for the treatment of upper urinary tract stones by retrograde intrarenal surgery (RIRS). One group used a 30W Holmium:yttrium-aluminum-garnet (Ho:YAG) laser and the other group a 60W Thulium fiber laser (TFL). Both groups started with similar lasing parameters, but it was allowed for the surgeon to change them during surgery. TFL was found to be superior regarding surgical time and stone-free rate. Some limitations of the study should be pointed out: 1) its single center design, 2) laser settings could be modified during surgery, and 3) probably the most important limitation was that laser power for Ho:YAG was half of the TFL. There is no comment in the article about how the sample size was calculated. An other study with a high power Ho:YAG laser didn’t observe the same differences between both groups {1}.
- 20 October 2022
- Published by H1 Connect
Faculty Opinions recommendation of Management of post TURP strictures.
This interesting publication evaluates the management of anterior urethral strictures after transurethral resection of the prostate in a very high-volume centre for urethroplasty in India. A total of 170 patients were included. Most patients were treated with urethroplasty, and a minimal number of patients were treated with urethral dilations. The main recommendation of the study is to use substitution urethroplasty in these cases. In most cases a dorsal approach was preferred, except in juxta-sphincteric stenosis where a ventral approach was chosen to maximize continence preservation.
- 20 October 2022
- Published by H1 Connect
Faculty Opinions recommendation of Management of post TURP strictures.
This interesting publication evaluates the management of anterior urethral strictures after transurethral resection of the prostate in a very high-volume centre for urethroplasty in India. A total of 170 patients were included. Most patients were treated with urethroplasty, and a minimal number of patients were treated with urethral dilations. The main recommendation of the study is to use substitution urethroplasty in these cases. In most cases a dorsal approach was preferred, except in juxta-sphincteric stenosis where a ventral approach was chosen to maximize continence preservation.
- 13 October 2022
- Published by H1 Connect
Faculty Opinions recommendation of Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial.
The HIVEC-II study is a prospective multicenter, randomized, open label, phase II study that took place in three hospitals in the United Kingdom and evaluated the benefit of applying chemohyperthermia (CHT) as an adjuvant therapy after transurethral resection of bladder tumors (TURB). The treatment arm of the study received Mitomycine C (MMC) together with hyperthermia delivered by the COMBAT system, which recirculates MMC heated to 43ºC. The control arm received only MMC. The primary endpoint was 24-month disease-free survival as determined via cystoscopy and urinary cytology. Analysis was by intention to treat. The study showed a lower disease free survival rate on the CHT group at a 24-month follow-up, suggesting the conclusion that there it no oncological benefit in applying CHT with MMC. Some possible limitations of the study might be that applying MMC in the immediate postoperative period or maintaining the treatment with MMC for 1 year could alter the results. We want to highlight the importance of publishing negative studies like this one to avoid publication bias. Trial registration details: ISRCTN 23639415.
- 13 October 2022
- Published by H1 Connect
Faculty Opinions recommendation of Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial.
The HIVEC-II study is a prospective multicenter, randomized, open label, phase II study that took place in three hospitals in the United Kingdom and evaluated the benefit of applying chemohyperthermia (CHT) as an adjuvant therapy after transurethral resection of bladder tumors (TURB). The treatment arm of the study received Mitomycine C (MMC) together with hyperthermia delivered by the COMBAT system, which recirculates MMC heated to 43ºC. The control arm received only MMC. The primary endpoint was 24-month disease-free survival as determined via cystoscopy and urinary cytology. Analysis was by intention to treat. The study showed a lower disease free survival rate on the CHT group at a 24-month follow-up, suggesting the conclusion that there it no oncological benefit in applying CHT with MMC. Some possible limitations of the study might be that applying MMC in the immediate postoperative period or maintaining the treatment with MMC for 1 year could alter the results. We want to highlight the importance of publishing negative studies like this one to avoid publication bias. Trial registration details: ISRCTN 23639415.
- 19 April 2022
- Published by H1 Connect
Faculty Opinions recommendation of Surgical Treatment for Recurrent Bulbar Urethral Stricture: A Randomised Open-label Superiority Trial of Open Urethroplasty Versus Endoscopic Urethrotomy (the OPEN Trial).
Open urethroplasty is considered, especially inside the reconstructive surgery community, as being superior to internal urethrotomy regarding patency. Despite this, there were no randomized controlled trials (RCTs) comparing both procedures. The OPEN trial, by Goulao et al., put an end to this situation by presenting an open-label RCT recruiting 53 centres across the UK healthcare system. We acknowledge the difficulty of performing this type of study and congratulate the authors on it. One interesting and slightly controversial aspect of the study is that the primary outcome was the variation of the voiding symptoms component of the patient-reported outcome measures (PROM) questionnaire. The authors explain this choice as an attempt to centre the study on the patient. Some authors have suggested that a more objective primary outcome would have been more robust. Nevertheless, some much more objective secondary outcomes allow the authors to achieve robust conclusions. Voiding symptoms are equal between both groups, but max flow rate, recurrence, and reintervention rates all favour open urethroplasty. Interestingly, adverse events were similar between groups, despite one would expect higher adverse events after a more invasive open approach. Trial registration details: ISRCTN98009168.
- 19 April 2022
- Published by H1 Connect
Faculty Opinions recommendation of Surgical Treatment for Recurrent Bulbar Urethral Stricture: A Randomised Open-label Superiority Trial of Open Urethroplasty Versus Endoscopic Urethrotomy (the OPEN Trial).
Open urethroplasty is considered, especially inside the reconstructive surgery community, as being superior to internal urethrotomy regarding patency. Despite this, there were no randomized controlled trials (RCTs) comparing both procedures. The OPEN trial, by Goulao et al., put an end to this situation by presenting an open-label RCT recruiting 53 centres across the UK healthcare system. We acknowledge the difficulty of performing this type of study and congratulate the authors on it. One interesting and slightly controversial aspect of the study is that the primary outcome was the variation of the voiding symptoms component of the patient-reported outcome measures (PROM) questionnaire. The authors explain this choice as an attempt to centre the study on the patient. Some authors have suggested that a more objective primary outcome would have been more robust. Nevertheless, some much more objective secondary outcomes allow the authors to achieve robust conclusions. Voiding symptoms are equal between both groups, but max flow rate, recurrence, and reintervention rates all favour open urethroplasty. Interestingly, adverse events were similar between groups, despite one would expect higher adverse events after a more invasive open approach. Trial registration details: ISRCTN98009168.